0

Back to The Clinical Laboratory and Transgender Healthcare
The Clinical Laboratory and Transgender Healthcare

The Clinical Laboratory and Transgender Healthcare

Release Date: Apr 2018

 

CC: PC, MK, PBL, ICS, PR, SBP

 

Matthew D. Krasowski, MD, PhD

Vice Chair of Clinical Pathology and Laboratory Services, University of Iowa Hospitals and Clinics, Iowa City, IA; Clinical Professor of Pathology, University of Iowa College of Medicine, Iowa City, IA

 

 

  

Description:

 

The transgender community has historically been one of the most marginalized populations with respect to healthcare. Fortunately, awareness of transgender healthcare issues is steadily increasing. This webcast focuses on the role of the clinical laboratory in providing optimal care for the transgender population. The first part of the presentation will review nomenclature, terminology, and barriers relevant to transgender healthcare. The importance of interactions between phlebotomy staff and frontline clerical staff with transgender patients will be discussed. Informatics challenges relative to patient gender identity, pronoun preference, and preferred name will be analyzed. The second part of the presentation will summarize common medical and surgical interventions for managing gender dysphoria along with consensus guidelines for laboratory monitoring. The last part of the presentation will synthesize current evidence on the effects of gender-affirming therapy on laboratory tests. Although definitive prospective reference range studies have yet to be performed in the transgender population, data from multiple retrospective studies provides useful information in guiding interpretation of laboratory testing in the transgender population. The presentation will conclude with future challenges and opportunities.

 

 

After attending this session, participants will be able to:

 

  • Define nomenclature, terminology, and system barriers relevant to transgender healthcare.
  • Describe medical and surgical gender-affirming interventions and the laboratory testing used to monitor therapy.
  • Identify laboratory tests whose interpretation is most likely to be affected by hormonal and surgical gender-affirming interventions.

 

Who should attend?  Practicing Pathologists, Residents, Doctoral Scientists, Pathologists’ Assistants, Laboratory Managers, Bench Supervisors, Bench Technologists and Technicians, Cytotechnologists, Phlebotomists, Students

  • List Price: $45.00
  • Member Price: $35.00
 
Want to save more?
Log into see if you qualify for a lower rate.
Members save $10.00 or more Join
Item Details:
The Clinical Laboratory and Transgender Healthcare
Back to The Clinical Laboratory and Transgender Healthcare

Bought This Bought That ...